dc.contributor.author
Ferrero Jimeno, Yanire
dc.contributor.author
Vinardell Martínez-Hidalgo, Ma. Pilar
dc.date.issued
2022-04-07T10:48:19Z
dc.date.issued
2022-04-07T10:48:19Z
dc.date.issued
2022-04-07T10:48:19Z
dc.identifier
https://hdl.handle.net/2445/184815
dc.description.abstract
Psoriasis is an autoimmune inflammatory skin disease characterized by the hyperproliferation of keratinocytes and anomalous keratinization, which generates white plaques. Currently, there is no cure for psoriasis, however, the available treatments are based on topical and systemic therapies, which have benefits but can cause side effects that limit their usage. Conventional topical treatments have several limitations that emphasize the lack of a cure and an effective treatment. For this reason, pharmacotherapy for psoriasis could benefit from advances in nanomedicine: the design of new nanosystems overcomes the limitations of conventional topical therapy. Thus, the application of nanotechnology could imply significant improvements to the topical treatment of psoriasis.
dc.format
application/pdf
dc.publisher
Universitat de Barcelona
dc.relation
Reproducció del document publicat a: http://www.edicions.ub.edu/revistes/edusfarm8/documentos/1335.pdf
dc.relation
Edusfarm, 2016, vol. 8, p. 43-61
dc.rights
cc-by-nc-nd (c) Universitat de Barcelona, 2016
dc.rights
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Bioquímica i Fisiologia)
dc.subject
Nanotecnologia
dc.subject
Fisiologia patològica
dc.subject
Nanotechnology
dc.subject
Pathological physiology
dc.title
Psoriasi: Fisiopatologia i aplicació de la nanotecnologia al tractament
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion